Top Story

Novocure reports positive phase 3 results for tumor treating fields therapy

Novocure reports positive phase 3 results for tumor treating fields therapy

03-Dec-2024

|

By Clara Rodriguez Fernandez

Editor's Choice

Körber absorbs Wilhelm Bähren to expand pharma packaging toolbox

Körber absorbs Wilhelm Bähren to expand pharma packaging toolbox

03-Dec-2024

Headlines

Portugal’s Hovione builds spray drying capacity in US and Ireland

FDA grants orphan drug designation to CervoMed’s dementia drug

Adragos Pharma snaps up Baccinex to expand CDMO network

AstraZeneca claims phase 3 success with combination therapy for...

How eCOA/ePRO is transforming clinical trials

Vaxess' Rachel Sha - 'own the seat at the table that you have and...

→

In focus

The intersection of ethics and AI in healthtech marketing: Insights from ObvioHealth

19-Nov-2024 By Liza Laws

Control Towers in clinical trials: Harnessing logistics best practice to address pain points in the clinical trials market

Paid for and content provided by DHL Supply Chain

How early utilisation of AI can de-risk and accelerate clinical development

19-Nov-2024 By Liza Laws

Insights into creating an inhaler product through jet milling

Paid for and in partnership with Lonza Small Molecules

Featured

Insight

Innovative approaches to opioid use disorder treatment

By Liza Laws

Innovative approaches to opioid use disorder treatment

Clinical trials & development

→

Phase 3 win for Protagonist Therapeutics with oral plaque psoriasis drug

Phase 3 win for Protagonist Therapeutics with oral plaque psoriasis drug

21-Nov-2024

By Helen Albert

US companies enhancing decentralized clinical trials

US companies enhancing decentralized clinical trials

13-Nov-2024

By Larissa Warneck-Silvestrin

Medable and Google Cloud partner to deliver digital clinical trials technology

Medable and Google Cloud partner to deliver digital clinical trials technology

13-Nov-2024

By Clara Rodriguez Fernandez

Partner insightMore →

Powered by Ingredients + Innovation

Content provided by Univar Solutions USA

Solution for challenging antibodies – Planova™ S20N

Content provided by Asahi Kasei Medical Co., Ltd.

Accurate determination of resin substitution in solid phase peptide synthesis

Content provided by Almac Group

Reliability, scale, and security of supply

Content provided by Univar Solutions USA

Markets & regulatory news

→

Adragos Pharma snaps up Baccinex to expand CDMO network

Adragos Pharma snaps up Baccinex to expand CDMO network

26-Nov-2024

Genesis Therapeutics partners with NVIDIA to boost AI-driven drug discovery

Genesis Therapeutics partners with NVIDIA to boost AI-driven drug discovery

15-Nov-2024

By Liza Laws

US companies enhancing decentralized clinical trials

US companies enhancing decentralized clinical trials

13-Nov-2024

By Larissa Warneck-Silvestrin

Medable and Google Cloud partner to deliver digital clinical trials technology

Medable and Google Cloud partner to deliver digital clinical trials technology

13-Nov-2024

By Clara Rodriguez Fernandez

Drug delivery & innovation

→

Brixton Biosciences: Drug-free pain relief for knee osteoarthritis

Brixton Biosciences: Drug-free pain relief for knee osteoarthritis

22-Nov-2024

Overcoming nonspecific binding challenges in pharmacokinetic assays

Overcoming nonspecific binding challenges in pharmacokinetic assays

14-Nov-2024

By Liza Laws

Insights from Tjoapack’s CEO: 35 years of pharma packaging:

Insights from Tjoapack’s CEO: 35 years of pharma packaging:

08-Nov-2024

By Liza Laws

Novo Nordisk signs $285 million deal for a once-monthly GLP-1 receptor agonist

Novo Nordisk signs $285 million deal for a once-monthly GLP-1 receptor agonist

07-Nov-2024

By Clara Rodriguez Fernandez

Expand your knowledge

Industry Newsletters

Choose from regular, topic-based and special edition briefings

Resource centre

Discover cutting edge insight from our partners

Events & webinars

Explore our programme of live & on-demand content